Announced Thu, 14 May · 18:46 IST

Link Pharma Chem Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 21/05/2026 ,inter alia, to consider and approve Audited Financial results ....

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
1-day move
₹28.89
prior close
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-3.1+0.5+3.4+0.4-3.1-9.3-5.7
Up moveDown movePending
AI summary

Link Pharma Chem Ltd has notified BSE that its Board of Directors meeting is scheduled for 21st May 2026 to consider and approve the Audited Financial Results for the quarter and financial year ended 31 March 2026. This is a standard regulatory intimation under SEBI Listing Regulations. The company has also confirmed that the trading window has been closed since 1st April 2026 and will reopen 48 hours after the results are declared. No financial figures or qualitative disclosures are included in this filing as it is merely a meeting notice.

Likely market impact

This is a routine procedural filing and does not contain any financial results or qualitative disclosures that would directly impact shareholders. The actual impact will depend on the financial results to be approved at this meeting.